On October 2 2018
writing on Pharma website
John Coreawrites
"Last week, a study appearing in the Journal of the American Medical Association (JAMA) Internal Medicine, evaluated the costs specifically associated with successful clinical trials for novel therapeutic medicines. The narrow findings of this study have been misconstrued to suggest that the research and development (R&D) investments needed to bring a new treatment to patients may not be as large as we thought.
Notably absent from the study findings were the R&D costs associated with the nearly 90 percent of medicines that never attain U.S. Food and Drug Administration approval. These setbacks, an inevitable part of the R&D process, are a major reason companies spend an average of $2.6 billion for every medicine they bring to market, according to the Tufts Center for the Study of Drug Development."
So the people who have to use the successful medication have to pay the bill for all the non successful ones.
So this is a different kind of socialism is it?
in fact most of these big companies simply buyout a small company which does the real innovation and brings the drug through all the phases of clinical trials and gets FDA approval and then gobbled up by the big pharma or it's stage 3 and stage 4 results are so good that the big pharma knows there is going to be a big pay off.
rest of the time they are simply rolling the dice. ( We the Public and patients should foot their bill based on what their gambling habits are like )
then these Big pharma companies bribe people in academic institutions, who prostitute their souls and come out with these inflated estimates.
like Tufts Center for the Study of Drug Development." does.
No comments:
Post a Comment